About the Foundation

The Foundation for Cancer Research Support (RakFond) is a non-profit organization whose main tasks include: financing research and development activities, development of new methods and tools for the prevention, diagnosis and treatment of cancer, promoting the development and improvement of research and scientific activities of research institutions, scientific centers, oncological hospitals, and individual specialists in the field of oncology. The Foundation was founded in 2017 and operates on the territory of the Russian Federation.

NEWS

VIEW ALL

19 Mar

The results of the research supported by the RakFond by Bulatov E.R.

Immunotherapy with genetically modified lymphocytes, such as CAR-T cells, is one of the most promising areas of modern basic and clinical oncology. A CAR-T cell is ... далее...

16 Mar

Dear Friends and Colleagues! Today, on March 16, Professor Boris Afanasyev, member of the Foundation’s Scientific Advisory Board, Doctor of Medical Sciences, ... далее...

2 Mar

Report on the results of the Foundation's operations in 2019

A report on the results of the Foundation's operations in 2019 has been posted on our website. It contains the detailed description of supported research, events, ... далее...

13 Feb

ASCO Clinical Cancer Advances 2020

Достижения клинической онкологии – это ежегодный отчет ASCO, которые выделяет наиболее значимые научные достижения прошедшего года и определяют исследовательские приоритеты, которые могут ускорить прогресс в противораковой борьбе. далее...

4 Feb

RakFond Announces a New Competition of Research Projects in Radiation Therapy

Today, on World Cancer Day, the Foundation for Cancer Research Support opens applications submission to the competition of research projects in radiation therapy in oncology. далее...

HOW TO INITIATE YOUR OWN CLINICAL STUDY

This year, a joint workshop by RUSSCO and RakFond within the XXIII Russian Oncology Congress was dedicated to conducting clinical trials in oncology. Leading experts shared their experiences and discussed examples of what is needed to initiate your own clinical study. далее...

Articles and Reviews

View All

19 Mar

The results of the research supported by the RakFond by Bulatov E.R.

Immunotherapy with genetically modified lymphocytes, such as CAR-T cells, is one of the most promising areas of modern basic and clinical oncology. A CAR-T cell is ... далее...

16 Mar

Dear Friends and Colleagues! Today, on March 16, Professor Boris Afanasyev, member of the Foundation’s Scientific Advisory Board, Doctor of Medical Sciences, ... далее...

2 Mar

Report on the results of the Foundation's operations in 2019

A report on the results of the Foundation's operations in 2019 has been posted on our website. It contains the detailed description of supported research, events, ... далее...

13 Feb

ASCO Clinical Cancer Advances 2020

4 Feb

RakFond Announces a New Competition of Research Projects in Radiation Therapy

Today, on World Cancer Day, the Foundation for Cancer Research Support opens applications submission to the competition of research projects in radiation therapy in oncology. далее...

HOW TO INITIATE YOUR OWN CLINICAL STUDY

Interviews with experts

RakFond's experts talk in their short interviews about their choice to become an oncologist, which cancer research they could name as their favorite, and why cancer research support is important.

19 Mar

The results of the research supported by the RakFond by Bulatov E.R.

Immunotherapy with genetically modified lymphocytes, such as CAR-T cells, is one of the most promising areas of modern basic and clinical oncology. A CAR-T cell is ... далее...

16 Mar

Dear Friends and Colleagues! Today, on March 16, Professor Boris Afanasyev, member of the Foundation’s Scientific Advisory Board, Doctor of Medical Sciences, ... далее...

2 Mar

About the Foundation

NEWS

Articles and Reviews

Interviews with experts

Our Supporters